CLOV vs MGRX · rev $1.37B vs rev $615.9K
Clover Health Investments Corp (CLOV) versus Mangoceuticals, Inc. Common Stock (MGRX) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Mangoceuticals, Inc. Common Stock (MGRX) is a health information services company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported MGRX revenue for 2024-12-31 was $615.9K. Net income was -$8.7M. Revenue was down 15.8% from 2023-12-31 to 2024-12-31. MGRX currently screens at market cap $16.3M.
CLOV currently screens at market cap $1.55B. MGRX currently screens at market cap $16.3M.
Not investment advice. Open the CLOV and MGRX stock pages for the full models.
Not investment advice.